Clinical Trial Award (Vision Research Program, FY26)
Funds early-phase clinical trials to speed development of treatments for military-related eye injuries or visual dysfunction, aiming for advances in prevention, diagnosis, and restoration of vision.
Funder: Military Health System Research Program
Due Dates (Anticipated): June 2026: Pre-application (preproposal) | September 2026: Full application (projected)
Funding Amounts: Up to $2.6 million total costs for up to 3 years (per award).
Summary: Supports early-phase clinical trials of interventions for military-related eye injuries or visual dysfunction, aiming to accelerate clinical impact in vision restoration and care.
Key Information: Preproposal required; full application by invitation only.
Description
This opportunity supports the rapid implementation of early-phase clinical trials (phase 0 through phase 2a) for new interventions targeting service-related eye injuries or visual dysfunction. The goal is to accelerate the clinical testing of promising treatments that address visual injuries or dysfunction from military exposures, such as combat operations or explosive devices. Projects must align with at least one of the Vision Research Program’s focus areas, emphasizing clinical relevance and the potential impact on prevention, diagnosis, stabilization, treatment, or restoration of visual function related to military service.
